Picture

HB-AECP® TOUCHSCREEN

Technical Parameters & Specification

Scientific Name  :     Enhanced External Counterpulsation Device
Item No               :      HB-AECP®
Material               :     Metal Frame for Main Support
Volume                :     2.5m3
Voltage                :     Single exchange 110V - 220V   50/60 Hz
Power Supply     :     ≤ 2600W
Dimension          :     L*W*H = 2010*780*700 (mm)
Net Weight          :     200 KG
​
Contraindications
Enhanced ECP Therapy should be used for the treatment of patients with:
  • Arrhytmias that interfere with machine triggering
  • Bleeding diathesis
  • Active thrombophlebitis,
  • Severe lower extremity vaso-occlusive disease,
  • Presence of a documented aortic aneurysm,
  • Requiring surgical repair,
  • Pregnancy.
Our Advantage
  1. Modern / Advanced Design ( All in One, Newest Style)
  2. Precise Calculation
          QRS trigger is more exact according to clinic test, which is                very important for Patient benefit " good treatment result". It is            calculated by our Dr.Wu professor who has 30 years ECP
          clinical experience.

     3.  Top Key Parts
  • Solenoid Valve: ECP Special Military Material
  • Compressors  : German BECKER
  • Transducers   :  German SIEMENS

      4.  HB-AECP have Accurate & Sensitive Response And                         Treatment for the premature patients. Full inflation and
           deflation when working, clinic result is better for patients.
      
 Precautions
​
  • Patients with blood pressure higher than 180/110mmHg
          should be controlled prior to treatment with enhanced ECP

  • Patients with a heart rate more than 120 bpm
          should be controlled prior to treatment with enhanced ECP

  • Patients at high risk of complications from increased venous return
          should be carefully chosen and monitored during treatment                with enhanced ECP.
          Decreasing cardiac afterload by optimizing diastolic                            augmentation may help minimize increased cardiac filling                  pressure due to venous return.

  • Patients with clinically significant valvular disease
          should be carefully chosen and monitored during treatment                with enhanced ECP.
          Certain valve conditions, such as significant aortic                              insufficiency, or severe mitral or aortic stenosis, may prevent              the patient from obtaining benefit from diastolic augmentation            and reduced cardiac afterload in the presence of increased                venous return.